Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Recruiting · NCT05933395 · Registry updated 2026-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 2 | 2026-01-20 | NCT05933395 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dartmouth-Hitchcock Medical Center | 104 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dartmouth Hitchcock Medical Center | Lebanon | United States | 79 |